カテゴリ： 世界, 医療/バイオ, QYResearch

腫瘍溶解性ウイルス薬物治療の世界市場2023年：フェーズ1、フェーズ2、その他

■ 英語タイトル：Global Oncolytic Virus Drug Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8833）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8833
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：85
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[腫瘍溶解性ウイルス薬物治療の世界市場2023年：フェーズ1、フェーズ2、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は腫瘍溶解性ウイルス薬物治療のグローバル市場について調査・分析し、世界の腫瘍溶解性ウイルス薬物治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（フェーズ1、フェーズ2、その他）、用途別セグメント分析（黒色腫、前立腺がん、乳がん、卵巣がん、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Amgen、Oncolytics Biotech、Viralytics、Transgene SA、Oncolys BioPharma、Targovax、PsiOxus Therapeutics、SillaJen Biotherapeutics、Sorrento Therapeutics、Lokon Pharma、Genelux Corporation、Vyriad、TILT Biotherapeutics、Cold Genesysなどが含まれています。腫瘍溶解性ウイルス薬物治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、腫瘍溶解性ウイルス薬物治療市場規模を算出する際に考慮しました。

・腫瘍溶解性ウイルス薬物治療市場の概要
- 腫瘍溶解性ウイルス薬物治療の種類別セグメント
- 世界の腫瘍溶解性ウイルス薬物治療市場規模：タイプ別分析（フェーズ1、フェーズ2、その他）
- 腫瘍溶解性ウイルス薬物治療の用途別セグメント
- 世界の腫瘍溶解性ウイルス薬物治療市場規模：用途別分析（黒色腫、前立腺がん、乳がん、卵巣がん、その他）
- 世界の腫瘍溶解性ウイルス薬物治療市場規模予測（2018年-2029年）

・腫瘍溶解性ウイルス薬物治療市場の成長トレンド
- 腫瘍溶解性ウイルス薬物治療の地域別市場規模（2018年-2029年）
- 腫瘍溶解性ウイルス薬物治療市場ダイナミクス
- 腫瘍溶解性ウイルス薬物治療の業界動向
- 腫瘍溶解性ウイルス薬物治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：フェーズ1、フェーズ2、その他
- 世界の腫瘍溶解性ウイルス薬物治療のタイプ別市場規模（2018年-2023年）
- 世界の腫瘍溶解性ウイルス薬物治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：黒色腫、前立腺がん、乳がん、卵巣がん、その他
- 世界の腫瘍溶解性ウイルス薬物治療の用途別市場規模（2018年-2023年）
- 世界の腫瘍溶解性ウイルス薬物治療の用途別市場規模（2024年-2029年）

・腫瘍溶解性ウイルス薬物治療の地域別市場規模
- 北米の腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- 米国の腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- ヨーロッパの腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- アジア太平洋の腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- 中国の腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- 日本の腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- 韓国の腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- インドの腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- オーストラリアの腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- 中南米の腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）
- 中東・アフリカの腫瘍溶解性ウイルス薬物治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Amgen、Oncolytics Biotech、Viralytics、Transgene SA、Oncolys BioPharma、Targovax、PsiOxus Therapeutics、SillaJen Biotherapeutics、Sorrento Therapeutics、Lokon Pharma、Genelux Corporation、Vyriad、TILT Biotherapeutics、Cold Genesys

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Oncolytic Virus Drug Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Oncolytic Virus Drug Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oncolytic Virus Drug Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Oncolytic Virus Drug Treatment in Melanoma is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Oncolytic Virus Drug Treatment include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Drug Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Drug Treatment.
The Oncolytic Virus Drug Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oncolytic Virus Drug Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus Drug Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Segment by Type
Phase 1
Phase 2
Others
Segment by Application
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncolytic Virus Drug Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Phase 1
1.2.3 Phase 2
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Drug Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Melanoma
1.3.3 Prostate Cancer
1.3.4 Breast Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Drug Treatment Market Perspective (2018-2029)
2.2 Oncolytic Virus Drug Treatment Growth Trends by Region
2.2.1 Global Oncolytic Virus Drug Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oncolytic Virus Drug Treatment Historic Market Size by Region (2018-2023)
2.2.3 Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2024-2029)
2.3 Oncolytic Virus Drug Treatment Market Dynamics
2.3.1 Oncolytic Virus Drug Treatment Industry Trends
2.3.2 Oncolytic Virus Drug Treatment Market Drivers
2.3.3 Oncolytic Virus Drug Treatment Market Challenges
2.3.4 Oncolytic Virus Drug Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue
3.1.1 Global Top Oncolytic Virus Drug Treatment Players by Revenue (2018-2023)
3.1.2 Global Oncolytic Virus Drug Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Oncolytic Virus Drug Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Drug Treatment Revenue
3.4 Global Oncolytic Virus Drug Treatment Market Concentration Ratio
3.4.1 Global Oncolytic Virus Drug Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Drug Treatment Revenue in 2022
3.5 Oncolytic Virus Drug Treatment Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Drug Treatment Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Drug Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Drug Treatment Breakdown Data by Type
4.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Type (2018-2023)
4.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Type (2024-2029)
5 Oncolytic Virus Drug Treatment Breakdown Data by Application
5.1 Global Oncolytic Virus Drug Treatment Historic Market Size by Application (2018-2023)
5.2 Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oncolytic Virus Drug Treatment Market Size (2018-2029)
6.2 North America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
6.4 North America Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Drug Treatment Market Size (2018-2029)
7.2 Europe Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
7.4 Europe Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Drug Treatment Market Size (2018-2029)
8.2 Asia-Pacific Oncolytic Virus Drug Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Drug Treatment Market Size (2018-2029)
9.2 Latin America Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
9.4 Latin America Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Drug Treatment Market Size (2018-2029)
10.2 Middle East & Africa Oncolytic Virus Drug Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Oncolytic Virus Drug Treatment Introduction
11.1.4 Amgen Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Oncolytics Biotech
11.2.1 Oncolytics Biotech Company Detail
11.2.2 Oncolytics Biotech Business Overview
11.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Introduction
11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.2.5 Oncolytics Biotech Recent Development
11.3 Viralytics
11.3.1 Viralytics Company Detail
11.3.2 Viralytics Business Overview
11.3.3 Viralytics Oncolytic Virus Drug Treatment Introduction
11.3.4 Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.3.5 Viralytics Recent Development
11.4 Transgene SA
11.4.1 Transgene SA Company Detail
11.4.2 Transgene SA Business Overview
11.4.3 Transgene SA Oncolytic Virus Drug Treatment Introduction
11.4.4 Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.4.5 Transgene SA Recent Development
11.5 Oncolys BioPharma
11.5.1 Oncolys BioPharma Company Detail
11.5.2 Oncolys BioPharma Business Overview
11.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Introduction
11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.5.5 Oncolys BioPharma Recent Development
11.6 Targovax
11.6.1 Targovax Company Detail
11.6.2 Targovax Business Overview
11.6.3 Targovax Oncolytic Virus Drug Treatment Introduction
11.6.4 Targovax Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.6.5 Targovax Recent Development
11.7 PsiOxus Therapeutics
11.7.1 PsiOxus Therapeutics Company Detail
11.7.2 PsiOxus Therapeutics Business Overview
11.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Introduction
11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.7.5 PsiOxus Therapeutics Recent Development
11.8 SillaJen Biotherapeutics
11.8.1 SillaJen Biotherapeutics Company Detail
11.8.2 SillaJen Biotherapeutics Business Overview
11.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Introduction
11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.8.5 SillaJen Biotherapeutics Recent Development
11.9 Sorrento Therapeutics
11.9.1 Sorrento Therapeutics Company Detail
11.9.2 Sorrento Therapeutics Business Overview
11.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Introduction
11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.9.5 Sorrento Therapeutics Recent Development
11.10 Lokon Pharma
11.10.1 Lokon Pharma Company Detail
11.10.2 Lokon Pharma Business Overview
11.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Introduction
11.10.4 Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.10.5 Lokon Pharma Recent Development
11.11 Genelux Corporation
11.11.1 Genelux Corporation Company Detail
11.11.2 Genelux Corporation Business Overview
11.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Introduction
11.11.4 Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.11.5 Genelux Corporation Recent Development
11.12 Vyriad
11.12.1 Vyriad Company Detail
11.12.2 Vyriad Business Overview
11.12.3 Vyriad Oncolytic Virus Drug Treatment Introduction
11.12.4 Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.12.5 Vyriad Recent Development
11.13 TILT Biotherapeutics
11.13.1 TILT Biotherapeutics Company Detail
11.13.2 TILT Biotherapeutics Business Overview
11.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Introduction
11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.13.5 TILT Biotherapeutics Recent Development
11.14 Cold Genesys
11.14.1 Cold Genesys Company Detail
11.14.2 Cold Genesys Business Overview
11.14.3 Cold Genesys Oncolytic Virus Drug Treatment Introduction
11.14.4 Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2018-2023)
11.14.5 Cold Genesys Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oncolytic Virus Drug Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Phase 1
Table 3. Key Players of Phase 2
Table 4. Key Players of Others
Table 5. Global Oncolytic Virus Drug Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Oncolytic Virus Drug Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Oncolytic Virus Drug Treatment Market Share by Region (2018-2023)
Table 9. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Oncolytic Virus Drug Treatment Market Share by Region (2024-2029)
Table 11. Oncolytic Virus Drug Treatment Market Trends
Table 12. Oncolytic Virus Drug Treatment Market Drivers
Table 13. Oncolytic Virus Drug Treatment Market Challenges
Table 14. Oncolytic Virus Drug Treatment Market Restraints
Table 15. Global Oncolytic Virus Drug Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Oncolytic Virus Drug Treatment Market Share by Players (2018-2023)
Table 17. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2022)
Table 18. Ranking of Global Top Oncolytic Virus Drug Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Oncolytic Virus Drug Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncolytic Virus Drug Treatment Product Solution and Service
Table 22. Date of Enter into Oncolytic Virus Drug Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncolytic Virus Drug Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Oncolytic Virus Drug Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Oncolytic Virus Drug Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Oncolytic Virus Drug Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Oncolytic Virus Drug Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Oncolytic Virus Drug Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Oncolytic Virus Drug Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Oncolytic Virus Drug Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Oncolytic Virus Drug Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Oncolytic Virus Drug Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Oncolytic Virus Drug Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Oncolytic Virus Drug Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Oncolytic Virus Drug Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen Oncolytic Virus Drug Treatment Product
Table 50. Amgen Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. Oncolytics Biotech Company Detail
Table 53. Oncolytics Biotech Business Overview
Table 54. Oncolytics Biotech Oncolytic Virus Drug Treatment Product
Table 55. Oncolytics Biotech Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 56. Oncolytics Biotech Recent Development
Table 57. Viralytics Company Detail
Table 58. Viralytics Business Overview
Table 59. Viralytics Oncolytic Virus Drug Treatment Product
Table 60. Viralytics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 61. Viralytics Recent Development
Table 62. Transgene SA Company Detail
Table 63. Transgene SA Business Overview
Table 64. Transgene SA Oncolytic Virus Drug Treatment Product
Table 65. Transgene SA Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 66. Transgene SA Recent Development
Table 67. Oncolys BioPharma Company Detail
Table 68. Oncolys BioPharma Business Overview
Table 69. Oncolys BioPharma Oncolytic Virus Drug Treatment Product
Table 70. Oncolys BioPharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 71. Oncolys BioPharma Recent Development
Table 72. Targovax Company Detail
Table 73. Targovax Business Overview
Table 74. Targovax Oncolytic Virus Drug Treatment Product
Table 75. Targovax Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 76. Targovax Recent Development
Table 77. PsiOxus Therapeutics Company Detail
Table 78. PsiOxus Therapeutics Business Overview
Table 79. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product
Table 80. PsiOxus Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 81. PsiOxus Therapeutics Recent Development
Table 82. SillaJen Biotherapeutics Company Detail
Table 83. SillaJen Biotherapeutics Business Overview
Table 84. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product
Table 85. SillaJen Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 86. SillaJen Biotherapeutics Recent Development
Table 87. Sorrento Therapeutics Company Detail
Table 88. Sorrento Therapeutics Business Overview
Table 89. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product
Table 90. Sorrento Therapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 91. Sorrento Therapeutics Recent Development
Table 92. Lokon Pharma Company Detail
Table 93. Lokon Pharma Business Overview
Table 94. Lokon Pharma Oncolytic Virus Drug Treatment Product
Table 95. Lokon Pharma Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 96. Lokon Pharma Recent Development
Table 97. Genelux Corporation Company Detail
Table 98. Genelux Corporation Business Overview
Table 99. Genelux Corporation Oncolytic Virus Drug Treatment Product
Table 100. Genelux Corporation Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 101. Genelux Corporation Recent Development
Table 102. Vyriad Company Detail
Table 103. Vyriad Business Overview
Table 104. Vyriad Oncolytic Virus Drug Treatment Product
Table 105. Vyriad Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 106. Vyriad Recent Development
Table 107. TILT Biotherapeutics Company Detail
Table 108. TILT Biotherapeutics Business Overview
Table 109. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product
Table 110. TILT Biotherapeutics Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 111. TILT Biotherapeutics Recent Development
Table 112. Cold Genesys Company Detail
Table 113. Cold Genesys Business Overview
Table 114. Cold Genesys Oncolytic Virus Drug Treatment Product
Table 115. Cold Genesys Revenue in Oncolytic Virus Drug Treatment Business (2018-2023) & (US$ Million)
Table 116. Cold Genesys Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Drug Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Oncolytic Virus Drug Treatment Market Share by Type: 2022 VS 2029
Figure 3. Phase 1 Features
Figure 4. Phase 2 Features
Figure 5. Others Features
Figure 6. Global Oncolytic Virus Drug Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Oncolytic Virus Drug Treatment Market Share by Application: 2022 VS 2029
Figure 8. Melanoma Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Breast Cancer Case Studies
Figure 11. Ovarian Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Oncolytic Virus Drug Treatment Report Years Considered
Figure 14. Global Oncolytic Virus Drug Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Oncolytic Virus Drug Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Oncolytic Virus Drug Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Oncolytic Virus Drug Treatment Market Share by Players in 2022
Figure 18. Global Top Oncolytic Virus Drug Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Drug Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Oncolytic Virus Drug Treatment Revenue in 2022
Figure 20. North America Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Oncolytic Virus Drug Treatment Market Share by Country (2018-2029)
Figure 22. United States Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Oncolytic Virus Drug Treatment Market Share by Country (2018-2029)
Figure 26. Germany Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Oncolytic Virus Drug Treatment Market Share by Region (2018-2029)
Figure 34. China Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Oncolytic Virus Drug Treatment Market Share by Country (2018-2029)
Figure 42. Mexico Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Oncolytic Virus Drug Treatment Market Share by Country (2018-2029)
Figure 46. Turkey Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Oncolytic Virus Drug Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Amgen Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 49. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 50. Viralytics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 51. Transgene SA Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 52. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 53. Targovax Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 54. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 55. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 56. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 57. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 58. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 59. Vyriad Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 60. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 61. Cold Genesys Revenue Growth Rate in Oncolytic Virus Drug Treatment Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 出血性疾患治療薬の世界市場2023年：経口式、静脈注射式、その他
  • 薬剤耐性結核治療薬の世界市場2023年：第一類抗結核薬、第二類抗結核薬、その他
  • 不活化ポリオワクチンの世界市場2023年：タイプⅠ、タイプⅡ、タイプⅢ
  • 四肢麻痺治療の世界市場2023年：経口、点滴、その他
  • 抗生物質の世界市場2023年：ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8833 )"腫瘍溶解性ウイルス薬物治療の世界市場2023年：フェーズ1、フェーズ2、その他" (英文：Global Oncolytic Virus Drug Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。